Femasys director granted options for 35,200 shares

Femasys Inc. director Kenneth D. Eichenbaum received a grant of stock options covering 35,200 shares of Common Stock.

Rhea-AI Filing Summary

Femasys Inc. director Kenneth D. Eichenbaum received a grant of stock options covering 35,200 shares of Common Stock. The options have an exercise price of $0.6000 per share and expire on March 18, 2036. This is a compensation-related award, not an open-market purchase or sale.

The award was reported as a direct holding. According to the footnote, the shares underlying the option will vest in annual one-third increments over a three-year period beginning on March 18, 2027, contingent on continued service. Following this grant, Eichenbaum holds 35,200 derivative securities of this type.

Insider Trade Summary

Grant/Award: 35,200 shares

Grant/Award 1 txn

Insider Eichenbaum Kenneth D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	35,200	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 35,200 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on March 18, 2027, assuming continued service.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kenneth D. Eichenbaum report in this FEMY Form 4 filing?

Kenneth D. Eichenbaum reported receiving a stock option grant for 35,200 shares of Femasys Inc. Common Stock. The option is a compensation award, not a market trade, and was reported as a direct derivative holding in this Form 4 filing.

What are the key terms of Kenneth Eichenbaum’s FEMY stock option grant?

The grant covers 35,200 shares of Femasys Common Stock at an exercise price of $0.6000 per share. The option expires on March 18, 2036, giving a long exercise window if the vesting and service conditions are satisfied over time.

How does the vesting schedule work for Kenneth Eichenbaum’s FEMY options?

The underlying shares vest in annual one-third increments over three years, beginning March 18, 2027. Vesting depends on continued service, meaning Eichenbaum must remain in his role for the options to fully become exercisable across that period.

Did Kenneth Eichenbaum buy or sell FEMY shares in the market in this filing?

No open-market buy or sell occurred; this filing reports a grant. The transaction code is “A” for a grant or award acquisition of stock options, which is a form of equity compensation rather than a discretionary market purchase or sale.

How many FEMY derivative securities does Kenneth Eichenbaum hold after this grant?

After this transaction, Eichenbaum holds 35,200 derivative securities of this stock option type. These options relate to the same number of Femasys Common Stock shares, subject to the stated $0.6000 exercise price and the three-year vesting schedule.

What role does Kenneth Eichenbaum hold at Femasys Inc. in this Form 4?

The Form 4 identifies Kenneth D. Eichenbaum as a director of Femasys Inc. The reported stock option grant represents part of his equity-based compensation, aligning his potential future economic interests with company performance over the option’s term.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/20/2026 - 06:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eichenbaum Kenneth D.

(Last) (First) (Middle)

C/O FEMASYS INC.

3950 JOHNS CREEK COURT, SUITE 100

(Street)

SUWANEE GEORGIA 30024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.6	03/18/2026		A		35,200		(1)	03/18/2036	Common Stock	35,200	$0	35,200	D

Explanation of Responses:

1. The shares underlying the stock option will vest in annual one-third (1/3) increments over a three (3) year period beginning on March 18, 2027, assuming continued service.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathy Lee-Sepsick, Attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)